ADIPOQ and chronic kidney disease: Rather, adiponectin paradox in patients with CKD could be attributed to alterations in the clearance of circulating adiponectin, as the renal clearance of adiponectin decreased in a mouse after subtotal nephrectomy, with an elevation of serum adiponectin levels (17).